New cocktail of drugs aims to tackle tough colorectal cancer
Disease control
Recruiting now
This phase 2 trial is testing whether adding two immune-boosting drugs (ongericimab and toripalimab) to standard second-line chemotherapy can shrink tumors in people with advanced MSS/pMMR colorectal cancer. The study enrolls 32 adults whose cancer progressed after first-line tre…
Phase: PHASE2 • Sponsor: Shanghai Pudong Hospital • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC